Optimi Health Completes Inaugural Export of MDMA Capsules to Australia for PTSD Treatment

August 16, 2024 7:30 AM EDT | Source: Optimi Health Corp. Vancouver, British Columbia–(Newsfile Corp. – August 16, 2024) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a GMP-approved, Health Canada-licensed psychedelics pharmaceutical manufacturer specializing in botanical psilocybin and MDMA, is pleased to announce it has completed the inaugural […]